Study guide
13.3 Postpartum Haemorrhage (PPH) Causes & Management
Combined Medical Services Examination UPSC CMS
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Logistics & Pattern
1.1 UPSC CMS Examination Overview & Eligibility 1.2 Two-Paper Written Exam Pattern & Negative Marking 1.3 Personality Test, Service Allocation & Career Paths
2 Chapter 2: General Medicine - Cardiology & Respiratory
2.1 Coronary Artery Disease & Acute Myocardial Infarction 2.2 Heart Failure & Cardiac Arrhythmias 2.3 Community-Acquired Pneumonia & Pulmonary Tuberculosis 2.4 COPD, Bronchial Asthma & Pulmonary Embolism
3 Chapter 3: General Medicine - Gastroenterology & Hepatology
3.1 Peptic Ulcer Disease & Upper GI Bleeding 3.2 Liver Cirrhosis & Portal Hypertension 3.3 Acute & Chronic Viral Hepatitis & Pancreatitis 3.4 Inflammatory Bowel Disease & Malabsorption Syndromes
4 Chapter 4: General Medicine - Nephrology & Endocrinology
4.1 Acute Kidney Injury & Chronic Kidney Disease 4.2 Glomerulonephritis, Nephrotic Syndrome & Electrolyte Imbalances 4.3 Diabetes Mellitus: Diagnosis, Complications & Management 4.4 Thyroid Disorders & Adrenal Gland Dysfunction
5 Chapter 5: General Medicine - Neurology, Haematology & Infection
5.1 Cerebrovascular Accidents (Stroke) & Epilepsy 5.2 Approach to Anaemia: Microcytic, Megaloblastic & Haemolytic 5.3 Acute & Chronic Leukaemias and Lymphomas 5.4 Tropical & Endemic Infections: Malaria, Typhoid & Dengue
6 Chapter 6: General Medicine - Emergency Medicine & Toxicology
6.1 Acute Anaphylaxis, Sepsis & Cardiopulmonary Resuscitation 6.2 Organophosphate, Paracetamol & Snakebite Toxicology 6.3 Common Dermatological & Psychiatric Manifestations in Internal Medicine 6.4 Musculoskeletal System & Adult Rheumatology
7 Chapter 7: Paediatrics - Neonatology & Child Growth
7.1 Newborn Care, Neonatal Resuscitation & APGAR Score 7.2 Prematurity, Low Birth Weight & Neonatal Jaundice 7.3 Infant & Child Growth & Developmental Milestones
8 Chapter 8: Paediatrics - Child Health & Nutrition
8.1 Protein-Energy Malnutrition (PEM) & Micronutrient Deficiencies 8.2 Universal Immunization Programme (UIP) & Child Vaccines 8.3 Pediatric Diarrhoea, Dehydration & Respiratory Emergencies 8.4 Birth Defects, Genetic Counseling, Autism & Paediatric Accidents/Poisoning
9 Chapter 9: Surgery - General Surgery, Wounds & Shock
9.1 Wound Healing, Surgical Site Infections & Gas Gangrene 9.2 Pathophysiology of Shock & Perioperative Fluid Therapy 9.3 Acute Abdomen: Appendicitis, Peritonitis & Intestinal Obstruction 9.4 Classification, Resuscitation & Management of Thermal Burns 9.5 Medicolegal & Ethical Issues in Surgery
10 Chapter 10: Surgery - Surgical Specialties I
10.1 Inguinal, Femoral & Ventral Hernias 10.2 Benign Breast Diseases & Breast Carcinoma 10.3 Solitary Thyroid Nodule & Thyroid Carcinoma 10.4 Benign Prostatic Hyperplasia & Renal Calculi
11 Chapter 11: Surgery - ENT, Orthopaedics & Anaesthesia
11.1 Acute Otitis Media, Tonsillitis & Epistaxis 11.2 Cataract, Glaucoma & Red Eye Emergencies 11.3 Principles of Fracture Management & Common Dislocation 11.4 Principles of Local, Regional & General Anaesthesia 11.5 Neurosurgery: Raised ICP, Head Injury & CNS Lesions 11.6 Thoracic Surgery: Chest Trauma, Pleural & Lung Disease
12 Chapter 12: Obstetrics - Antenatal Care & Complications
12.1 Antenatal Care, Maternal Nutrition & Fetal Assessment 12.2 Preeclampsia, Eclampsia & Gestational Hypertension 12.3 Antepartum Haemorrhage: Placenta Previa & Abruptio Placentae 12.4 Anemia in Pregnancy & Gestational Diabetes Mellitus 12.5 Spontaneous & Recurrent Abortion: Recognition & Management
13 Chapter 13: Obstetrics & Gynaecology - Labor & PPH
13.1 Normal Labor Mechanisms & Partograph Monitoring 13.2 Malpresentations, Breech & Obstructed Labor 13.3 Postpartum Haemorrhage (PPH) Causes & Management 13.4 Puerperal Sepsis & Postnatal Maternal Care
14 Chapter 14: Gynaecology & Family Planning
14.1 Abnormal Uterine Bleeding & Uterine Fibroids 14.2 Cervical Screening (Pap Smear) & Pelvic Inflammatory Disease 14.3 Temporary & Permanent Contraceptive Methods in India 14.4 Medical Termination of Pregnancy (MTP): Law & Methods
15 Chapter 15: PSM - Epidemiology & Biostatistics
15.1 Principles of Epidemiology & Disease Transmission 15.2 Observational & Experimental Epidemiological Study Designs 15.3 Evaluation of Screening Tests: Sensitivity, Specificity & Predictive Value 15.4 Biostatistics: Sampling, Central Tendency & Significance Testing
16 Chapter 16: PSM - Disease Epidemiology & Programmes
16.1 Epidemiology & Control of TB, Malaria & Dengue 16.2 National Tuberculosis Elimination Programme & NVBDCP 16.3 Epidemiology of Hypertension, Diabetes & Cancer in India 16.4 Cold Chain Management & Vaccine Logistics in India 16.5 Genetics and Health: Inheritance, Screening & Counseling
17 Chapter 17: PSM - Health Planning & Environmental Health
17.1 Demography, Fertility Rates & Family Welfare Indicators 17.2 Safe Water Supply, Waste Disposal & Air Pollution 17.3 Occupational Health Hazards & Pneumoconioses 17.4 Health Care Delivery System, Ayushman Bharat & National Health Mission 17.5 International Health: WHO, Global Agencies & SDG 3 17.6 Medical Sociology & Health Education
13.3 Postpartum Haemorrhage (PPH) Causes & Management
Key Takeaways Explain This Topic AI
Primary PPH is defined as blood loss ≥ 500 mL following vaginal delivery or ≥ 1000 mL following C-section within 24 hours of birth; severe PPH is blood loss ≥ 1000 mL.
The 4 Ts summarize PPH etiology: Tone (uterine atony ~70-80%), Trauma (lacerations/rupture ~20%), Tissue (retained placenta ~10%), and Thrombin (coagulopathy <1%).
Medical management of atonic PPH includes IV oxytocin, IM methylergometrine (contraindicated in hypertension), IM carboprost (PGF2α, contraindicated in asthma), misoprostol, and early IV tranexamic acid (within 3 hours).
Refractory atonic PPH requires mechanical balloon tamponade (Bakri balloon), surgical compression sutures (B-Lynch/Hayman), pelvic vessel ligation, or emergency hysterectomy.
Acute uterine inversion presents with severe neurogenic and hemorrhagic shock out of proportion to visible blood loss; immediate management requires manual replacement (Johnson's maneuver) before removing the placenta.
Last updated: July 2026
- Postpartum Haemorrhage (PPH) Causes & Management
- 1. Definition and Classification of Postpartum Haemorrhage
Postpartum Haemorrhage (PPH) remains the leading cause of maternal mortality worldwide and a high-frequency topic in the UPSC CMS examination.
Definitions
Primary PPH: Excessive blood loss occurring within 24 hours of childbirth .
Vaginal Delivery: Cumulative blood loss ≥ 500 mL (or any blood loss causing hemodynamic instability).
Cesarean Section: Cumulative blood loss ≥ 1000 mL .
Severe PPH: Cumulative blood loss ≥ 1000 mL regardless of delivery route.
Secondary (Late) PPH: Excessive vaginal bleeding occurring between 24 hours and 12 weeks postpartum (most commonly between days 8–14 postpartum due to retained placental tissue or uterine infection).
2. Etiology: The 4 Ts Framework
The primary causes of PPH are systematically categorized using the 4 Ts framework :
Category Frequency Primary Causes & Clinical Features
Tone (Uterine Atony) 70–80% Failure of the myometrium to contract and compress criss-cross muscular bundles ("living ligatures"). Soft, boggy, relaxed uterus above umbilicus. Risk factors: overdistended uterus (twins, polyhydramnios, macrosomia), prolonged/precipitate labor, grand multiparity, chorioamnionitis, halogenated anesthetics.
Trauma 15–20% Lacerations of perineum, vagina, cervix, or lower uterine segment; uterine rupture; acute uterine inversion. Uterus is firmly contracted , but bright red vaginal bleeding persists continuously. Risk factors: operative vaginal delivery (forceps/vacuum), precipitous delivery, fetal macrosomia.
Tissue 10% Retained placenta, succenturiate lobe, cotyledons, or blood clots; placenta accreta spectrum (accreta, increta, percreta). Incomplete placenta on inspection; persistent bleeding with soft uterus.
Thrombin (Coagulopathy) <1% Pre-existing bleeding disorders (hemophilia, von Willebrand disease, ITP) or acquired coagulopathies (DIC secondary to abruptio placentae, severe preeclampsia/HELLP, amniotic fluid embolism, dead fetus syndrome). Generalized oozing from puncture sites, episiotomy, and venipunctures; absence of clot formation.
3. Medical Management Protocol for Atonic PPH
When atonic PPH is identified, immediate simultaneous resuscitation and therapeutic intervention must be initiated:
Step 1: Immediate Resuscitation & Diagnostic Checks
Call for emergency obstetric assistance.
Airway, Breathing, Circulation (ABC): Administer high-flow oxygen (10–15 L/min).
Establish two large-bore IV lines (16G or 18G) . Draw blood for CBC, blood group & crossmatch, coagulation profile, and serum electrolytes.
Rapid infusion of warmed crystalloids (Ringer's Lactate or Normal Saline).
Perform bimanual uterine compression (one fist in anterior vaginal fornix, other hand on abdominal wall compressing posterior uterine wall).
Insert Foley catheter to empty bladder (a full bladder inhibits uterine contraction).
Inspect birth canal thoroughly with speculum to rule out traumatic lacerations.
Step 2: Uterotonic Pharmacotherapy
Oxytocin (First-Line):
Dose: 10–40 IU in 1000 mL Normal Saline or Ringer's Lactate IV infusion at 125–250 mL/hr (or 10 IU IM).
Caution: Never give as a rapid IV bolus (causes severe hypotension, arrhythmias, and cardiac collapse).
Tranexamic Acid (TXA):
Dose: 1 gram IV over 10 minutes within 3 hours of birth (WOMAN trial protocol). Repeat 1g IV after 30 minutes if bleeding continues or restarts within 24 hours.
Methylergometrine / Ergometrine:
Dose: 0.2 mg IM or slow IV.
Action: Causes sustained tetanic uterine contractions.
Absolute Contraindications: Hypertension, Preeclampsia, Eclampsia, Heart Disease (causes severe vasoconstriction and hypertensive crisis).
Carboprost Tromethamine (15-methyl PGF2α):
Dose: 0.25 mg (250 mcg) deep IM every 15 to 90 minutes (maximum 8 doses = 2 mg).
Absolute Contraindications: Asthma or active reactive airway disease (causes severe bronchospasm). Relative contraindication: hepatic or cardiac disease.
Misoprostol (PGE1 synthetic analog):
Dose: 600–800 mcg sublingually, orally, or rectally.
Advantage: Thermostable, no refrigeration needed; valuable in low-resource settings.
4. Mechanical & Surgical Interventions for Refractory PPH
If bleeding persists despite full uterotonic therapy and TXA:
Intrauterine Balloon Tamponade (IBT):
Insertion of a Bakri balloon , condom catheter, or Foley catheter bundle into the uterine cavity, inflated with 300–500 mL of warm sterile saline. Provides internal mechanical pressure against uterine walls. Effective in ~85% of cases.
Surgical Uterine Compression Sutures:
B-Lynch Suture: Continuous brace suture wrapping around the uterus from anterior to posterior wall, compressing the uterine corpus.
Hayman / Cho Modification Sutures: Vertical transfixing sutures.
Surgical Vessel Ligation (Stepwise Devascularization):
Bilateral Uterine Artery Ligation (O'Leary stitches).
Bilateral Utero-Ovarian Artery Ligation.
Bilateral Internal Iliac (Hypogastric) Artery Ligation: Ligates the anterior division of internal iliac artery; reduces pelvic pulse pressure by ~85% without sacrificing pelvic tissue viability.
Uterine Artery Embolization (UAE): Performed by interventional radiology if patient is hemodynamically stable.
Subtotal or Total Emergency Peripartum Hysterectomy: Ultimate life-saving procedure when all conservative surgical interventions fail.
5. Management of Acute Uterine Inversion
Uterine inversion is a life-threatening obstetric emergency where the fundus turns inside out into the uterine cavity or through the cervix/vagina.
Etiology & Presentation
Causes: Mismanaged third stage—applying strong fundal pressure or cord traction on an unseparated placenta when the uterus is atonic.
Clinical Presentation: Profuse vaginal bleeding accompanied by severe neurogenic and hemorrhagic shock . The shock is disproportionately greater than visible blood loss due to parasympathetic vagal stimulation from traction on pelvic peritoneum and ovaries.
Management Steps
Stop all uterotonic agents immediately (they prevent manual reduction by causing cervical ring spasm).
Johnson's Maneuver: Grasp the inverted fundus with the palm in the vagina and push it upwards through the cervical ring toward the umbilicus, returning the fundus to its anatomical position.
Placental Removal: Remove placenta ONLY AFTER successful manual replacement of the uterus. (Removing placenta first increases fatal hemorrhage).
If manual replacement fails: O'Sullivan's Hydrostatic Method (instilling warm saline into vagina via douche nozzle to create hydrostatic pressure) or surgical correction ( Huntington or Haultain operation ).
Give IV uterotonics immediately AFTER uterine replacement to prevent re-inversion.